retired doc's thoughts

TORCH stands for " To wards a R evolution in C OPD H ealth" and may well earn the yearly prize for the most self aggrandizing name...

Perhaps goaded on- in part by the urging of insurers and third party payers to save money- we are from time to time treated to a commentar...

An editorial by Geoffrey Norman, Ph.D entitled "Building on Experience-The Development of Clinical Reasoning" is found in the Nove...

I have written several times before on the SMART trial and the meta-analysis (MA) written by the Salpeter family team in the Annals of Int...

Nothing seems secure from progress or change or innovation.The Mantoux skin test has been around for over 60 years and is now being challen...

The SPORT trial results are published in the November 22,2006 issue of JAMA. The Spine Patient Outcomes Research Trial was a 501 patient ran...

The American College of Physicians (ACP) has supported P4P. An organization,the American Board of Internal Medicine,frequently sees eye to e...

That thiazides precipitate "benign"diabetes is, in part, the argument made in the recent issue of the Archives of Internal Medicin...

Dr. Edmund Blum, an internist from Brooklyn makes the argument that pay for performance (P4P) involves a "irresolvable conflict "...

According to an article in the November 1, 2006 of Internal medicine News (www.internalmedicine.com) six Washington state physicians and th...

Dr. John W. Rowe, who is not without impressive academic credentials, recently retired as CEO of Aetna recently authored a five page article...

Dr. Elliot S. Fisher is the author for the NEJM piece "Paying for Performance-Risks and Recommendations" (NEJM 355:18 1845). Dr. F...

In the October 26,2006 issue of the New England Journal of Medicine we find a clinical study and an editorial about lung cancer screening us...

A commentary appears in the October 19,2006 issue of the New England Journal of Medicine regarding allegations about the length to which a...

A thought provoking-and in a way troubling review- in the October 3, 2006 issue of the Annals of Internal Medicine ( "Lack of Evidence ...

The October 12, 2006 issue of The New England Journal of Medicine published an article regarding the use of the second generation antipsych...

A recent article in the September/October issue of the Journal of the American Board of Family Practice by David Hildebrandt called atte...

The editorial commentary by David Graham in the October 4,2006 issue of the Journal of the American Medical Association ("COX-2 Inhibit...

In the 1960s, the phenothiazines changed the face of psychiatry when chlorpromazine was shown to be effective treatment for schizophrenia. T...

I written before about the demise of the doctor's lounge in the hospital-the previous site of free coffee, curb stone consultations, ph...